Vladimir Zorin

Dr. Vladimir Zorin


Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2005 in Biochimica et Biophysica Acta (BBA) - General Subjects
Verified
Journal Article
Closed access
SSSiarhei Sasnouski
Siarhei Sasnouski
VZVladimir Zorin
Vladimir Zorin
IKIvan Khludeyev
Ivan Khludeyev
MDMarie-Ange D'Hallewin
Marie-Ange D'Hallewin
FGFrançois Guillemin
François Guillemin
LBLina Bezdetnaya
Lina Bezdetnaya

19 May 2012 in Photochemistry and Photobiology
Verified
Journal Article
Closed access
PDF file
VRVadzim Reshetov
Vadzim Reshetov
VZVladimir Zorin
Vladimir Zorin
ASAgnieszka Siupa
Agnieszka Siupa
MDMarie‐Ange D’hallewin
Marie‐Ange D’hallewin
FGFrançois Guillemin
François Guillemin
LBLina Bezdetnaya
Lina Bezdetnaya

1 October 2013 in International Journal of Nanomedicine
Verified
Journal Article
Open access
VRVadzim Reshetov
Vadzim Reshetov
HLHenri-Pierre Lassalle
Henri-Pierre Lassalle
AFAurélie François
Aurélie François
DDDominique Dumas
Dominique Dumas
SHSebastien Hupont
Sebastien Hupont
LBLina Bezdetnaya
Lina Bezdetnaya
Peer reviewed article authored by (Reshetov V, Lassalle HP, François A, Dumas D, Hupont S, Gräfe S, Filipe V, Jiskoot W, Guillemin F, Zorin V, Bezdetnaya L). Read article or submit your manuscript for publishing.

10 February 2011 in Photochemical & Photobiological Sciences
Verified
Journal Article
Closed access
PDF file
VRVadzim Reshetov
Vadzim Reshetov
DKDzmitry Kachatkou
Dzmitry Kachatkou
TSTatiana Shmigol
Tatiana Shmigol
VZVladimir Zorin
Vladimir Zorin
MDMarie-Ange D’hAllewin
Marie-Ange D’hAllewin
LBLina Bezdetnaya
Lina Bezdetnaya
We used the phenomenon of previously described photoinduced fluorescence quenching and fluorescence polarization to evaluate the transfer of meta-tetra(hydroxyphenyl)chlorin (m-THPC) from commercial high-drug load liposomes to plasma proteins and model membranes. Fluorescence quenching of m-THPC in liposomes by iodide indicates that part of m-THPC in PEGylated liposomes is localized in the PEG shell, while the rest is bound to the lipid bilayer. It was shown that the two molecule pools in the commercial PEGylated liposomal formulation Fospeg® condition the characteristics of the m-THPC release kinetics. A substantial percentage of m-THPC from Fospeg® is released much faster than from the conventional liposomal formulation Foslip®. Using the technique of resonance light scattering, it was shown that partial m-THPC aggregation is present in liposomes with very high drug loads, higher in PEGylated liposomes compared to conventional ones.

1 August 2016 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
IYIgor Yankovsky
Igor Yankovsky
EBEstelle Bastien
Estelle Bastien
Ilya YakavetsIlya Yakavets
Ilya Yakavets
IKIvan Khludeyev
Ivan Khludeyev
HLHenri-Pierre Lassalle
Henri-Pierre Lassalle
VZVladimir Zorin
Vladimir Zorin

18 October 2018 in Nanomaterials
Verified
Journal Article
Open access
PDF file
Ilya YakavetsIlya Yakavets
Ilya Yakavets
HLHenri-Pierre Lassalle
Henri-Pierre Lassalle
DSDietrich Scheglmann
Dietrich Scheglmann
AWArno Wiehe
Arno Wiehe
VZVladimir Zorin
Vladimir Zorin
LBLina Bezdetnaya
Lina Bezdetnaya
The main goal of this study was to use hybrid delivery system for effective transportation of temoporfin (meta-tetrakis(3-hydroxyphenyl)chlorin, mTHPC) to target tissue. We suggested to couple two independent delivery systems (liposomes and inclusion complexes) to achieve drug-in-cyclodextrin-in-liposome (DCL) nanoconstructs. We further optimized the composition of DCLs, aiming to alter in a more favorable way a distribution of temoporfin in tumor tissue. We have prepared DCLs with different compositions varying the concentration of mTHPC and the type of β-cyclodextrin (β-CD) derivatives (Hydroxypropyl-, Methyl- and Trimethyl-β-CD). DCLs were prepared by thin-hydration technique and mTHPC/β-CD complexes were added at hydration step. The size was about 135 nm with the surface charge of (−38 mV). We have demonstrated that DCLs are stable and almost all mTHPC is bound to β-CDs in the inner aqueous liposome core. Among all tested DCLs, trimethyl-β-CD-based DCL demonstrated a homogenous accumulation of mTHPC across tumor spheroid volume, thus supposing optimal mTHPC distribution.